Missions
- Excellent Science
-
Global Challenges and Competitiveness
- Cluster 1 - Health
- Cluster 2 - Culture, Creativity and Inclusive Society
- Cluster 3 - Civil Security for Society
- Cluster 4 - Digital, Industry and Space
- Cluster 5 - Climate, Energy and Mobility
- Cluster 6 - Food, Bioeconomy, Natural Resources, Agriculture and Environment
- Non - nuclear direct actions of the Joint Research Centre
- Innovative Europe
- Widening Participation and Strengthening the ERA
- Euratom
- Missions
-
European Partnerships
- Health
-
Digital, Industry and Space
- High Performance Computing
- Key Digital Technologies (KDT)
- Smart Networks and Services
- Artifical Intelligence, Data and Robotics
- Photonics
- Clean Steel - Low Carbon Steelmaking
- European Metrology
- Made in Europe
- Processes4Planet – Transforming the European Process Industry for a sustainable society
- Globally competitive Space Systems
- Geological Service for Europe
-
Climate, Energy and Transport
- Transforming Europe's rail system
- Integrated Air Traffic Management (ATM)
- Clean Aviation
- Clean Hydrogen
- People-centric sustainable built environment (Built4People)
- Towards zero-emission road transport (2ZERO)
- Connected and Automated Driving (CCAM)
- Zero-emission waterborne transport
- Industrial Battery Value Chain
- Driving urban transitions to a sustainable future (DUT)
- Clean Energy Transition
-
Food, Bioeconomics, Natural Resources, Agriculture and Environment
- Accelerating farming systems transition: agro-ecology living labs and research infrastructures
- Animal health (PAH)
- Agriculture of data
- Rescuing biodiversity to safeguard life on Earth
- A climate neutral, sustainable and productive Blue Economy
- Safe and Sustainable Food Systems
- Circular bio-based Europe
- Water security for the planet (Water4All)
- Cross - cutting partnerships
- ERA, EU programmes, funds and initiatives
Missions
- Excellent Science
-
Global Challenges and Competitiveness
- Cluster 1 - Health
- Cluster 2 - Culture, Creativity and Inclusive Society
- Cluster 3 - Civil Security for Society
- Cluster 4 - Digital, Industry and Space
- Cluster 5 - Climate, Energy and Mobility
- Cluster 6 - Food, Bioeconomy, Natural Resources, Agriculture and Environment
- Non - nuclear direct actions of the Joint Research Centre
- Innovative Europe
- Widening Participation and Strengthening the ERA
- Euratom
- Missions
-
European Partnerships
- Health
-
Digital, Industry and Space
- High Performance Computing
- Key Digital Technologies (KDT)
- Smart Networks and Services
- Artifical Intelligence, Data and Robotics
- Photonics
- Clean Steel - Low Carbon Steelmaking
- European Metrology
- Made in Europe
- Processes4Planet – Transforming the European Process Industry for a sustainable society
- Globally competitive Space Systems
- Geological Service for Europe
-
Climate, Energy and Transport
- Transforming Europe's rail system
- Integrated Air Traffic Management (ATM)
- Clean Aviation
- Clean Hydrogen
- People-centric sustainable built environment (Built4People)
- Towards zero-emission road transport (2ZERO)
- Connected and Automated Driving (CCAM)
- Zero-emission waterborne transport
- Industrial Battery Value Chain
- Driving urban transitions to a sustainable future (DUT)
- Clean Energy Transition
-
Food, Bioeconomics, Natural Resources, Agriculture and Environment
- Accelerating farming systems transition: agro-ecology living labs and research infrastructures
- Animal health (PAH)
- Agriculture of data
- Rescuing biodiversity to safeguard life on Earth
- A climate neutral, sustainable and productive Blue Economy
- Safe and Sustainable Food Systems
- Circular bio-based Europe
- Water security for the planet (Water4All)
- Cross - cutting partnerships
- ERA, EU programmes, funds and initiatives
Back
Institute of Hematology and Blood Transfusion is looking for partners for two Mission cancer topics
May 12, 2022
Topics:
HORIZON MISS 2022 CANCER 01 02: Strengthen ing research capacities of Comprehensive Cancer Infrastructures
HORIZON MISS 2022 CANCER 01 03: Pragmatic clinical trials to optimise treatments for patients with refractory cancers
See the attached document for details.